Visceral leishmaniasis (kala-azar) and pregnancy

Infectious Disease in Obstetrics and Gynecology

Volumn 12, Issue 1, 2004, Pages 31-40

  Figueiró Filho, Ernesto Antonio ^a,b   Duarte, Geraldo ^a   El Beitune, Patrícia ^a   Quintana, Silvana Maria ^a   Maia, Tamara Lemos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Amphotericin B; Congenital infection; Review; Tropical infection; Vertical transmission

Indexed keywords

AMPHOTERICIN B; MEGLUMINE ANTIMONATE;

ABDOMINAL PAIN; ANOREXIA; ARTHRALGIA; ASTHENIA; CARDIOTOXICITY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG CONTRAINDICATION; DRUG FEVER; EDEMA; FEMALE; GASTROINTESTINAL TOXICITY; GESTATION PERIOD; HEADACHE; HEART PALPITATION; HEARTBURN; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INJECTION PAIN; INSOMNIA; IRRITABILITY; LABORATORY TEST; LEISHMANIA CHAGASI; MEDICAL INFORMATION; MUSCLE WEAKNESS; MYALGIA; NAUSEA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PRURITUS; REVIEW; SHOCK; TREATMENT WITHDRAWAL; VERTICAL TRANSMISSION; VISCERAL LEISHMANIASIS; VOMITING;

AMPHOTERICIN B; ANTIMONY; ANTIPROTOZOAL AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; LEISHMANIASIS, VISCERAL; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

EID: 3142684042     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/1064744042000210384     Document Type: Review

References (41)

1. Alencar JE, Neves J, Dietze R. Leishmaniose visceral (calazar). In Veronesi R, Focaccia R, Dietze R, eds. Tratado de Infectologia, 9th edn. São Paulo: Atheneu, 1997
2. BRASIL. Fundação Nacional de Saúde. Guia de Vigilânda Epidemiológic, 5th edn. Brasilia, 2002
3. BRASIL. Fundação Nacional de Saúde. Doenças Infecciosas e Parasitárias. Guia de Bolso, 1st edn. Brasília, 1999
4. Meinecke CK, Schottelius J, Oskam L, et al. Congenital transmission of visceral leishmaniasis (kala azar) from an asymptomatic mother to her child. Pediatrics 1999;104:e65
5. Manson-Bahr PEC. Leishmaniasis. In: Hoeprich PD, Jordan MC, Ronald AR, eds. Infectious Diseases. A Treatise of Infectious Processes, 5th edn. Philadelphia: J.B. Lippincott Company, 1994
6. Pearson RD, Sousa AQ. Leishmania species: visceral (kala-azar), cutaneous and mucosal leishmaniasis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. London: Churchill Livingstone, 2000
7. Fundação Nacional de Saúde (FNS). Controle, diagnóstico e tratamento de Leishmaniose Visceral (Calazar). Brasília: Ministério da Saúde, Brasil, 1996
8. Vieira JBF, Coelho GE. Leishmaniose visceral ou calazar: aspectos epidemiológicos e de controle. Rev Soc Bras Med Trop 1998;31(SupplI):85- 92
9. Caldas AJM, Costa JML, Gama MEA et al. Visceral leishmaniasis in pregnancy: a case report. Acta Tropica 2003;88:39-43
10. Nuwayri-Salti N, Khansa HF. Direct non-insect-vector transmission of Leishmania parasites in mice. Int J Parasitol 1985;15:497-500
11. Gimbo A, Scirpo A, Ferro D, et al. Leishmania sp. in the submucosa of maternal post-abortive placenta in bitch. Parasitologia 1996;38:313
12. Andrade HM, Toledo VPCP, Marques MJ, et al. Leishmania (Leishmania) chagasi is not vertically transmitted in dogs. Vet Parasitol 2002;103:71-81
13. Krakowka S. Transplacentally acquired microbial and parasitic diseases of dogs. J Am Vet Med Assoc 1977;171:750-3
14. Harvey JW, Taboada J, Lewis JC. Babesiosis in a litter of pups. J Am Vet Med Assoc 1986;192:1751-2
15. Dubey JP, Koestner A, Piper RC. Repeated transplacental transmission of Neospora caninum in dogs. J Am Vet Med Assoc 1990;197:857-60
16. Barber JS, Trees AJ. Naturally occurring vertical transmission of Neospora caninum in dogs. Int J Parasitol 1998;28:57-64
17. Gtler RE, Lauricella MA, Solarz ND, et al. Dynamics of transmission of Trypanosoma cruzi in a rural area of Argentina. Rev Inst Med Trop São Paulo 1986;28:28-35
18. Low GC, Cooke WE. A congenital infection of kala-azar. Lancet 1926;ii:1209-11
19. Banerji D. Possible congenital infection of kala-azar. J Indian Med Assoc 1955;24:433-5
20. Blanc C, Robert A. Cinquième observation de kala-azar congénital. La Presse Médicale 1984;13:1751
21. Mittal V, Sehgal S, Yadav TP, et al. Congenital transmission of Kala-azar. J Commun Dis 1987;19:184-5
22. Nyakundi PM, Muigai R, Were JBO, et al. Congenital visceral leishmaniasis: case report. Trans R Soc Trop Med Hyg 1988;82:564
23. Yadav TP, Gupta H, Satteya U, et al. Congenital kala-azar. Ann Trop Med Parasitol 1989;83:535-7
24. Eltoum IA, Zijlstra EE, Ali MS, et al. Congenital kala-azar and leishmaniasis in the placenta. Am J Trop Med Hyg 1992;6:57-62
25. Elamin A, Omer MIA. Visceral leishmaniasis in a 6-week-old infant: possible congenital transmission. Trop Doct 1992;22:133-5
26. Sharma R, Bahl L, Goel A, et al. Congenital kala-azar: a case report. J Commun Dis 1996;28:59-61
27. Thakur CP, Sinha GP, Sharma V, et al. The treatment of leishmaniasis during pregnancy. Natl Med J India 1993;6:263-5
28. Grandoni L, Gaeta GB, Pellizzer G, et al. Mediterranean visceral leishmaniasis in pregnancy. Scand J Infect Dis 1994;26:627-9
29. Utili R, Rambaldi A, Tripodi MF, et al. Visceral leishmaniasis during pregnancy treated with meglumine antimonate. Infection 1995;23:182-3
30. Kumar A, Mittal M, Prasad S. Treatment of leishmaniasis in pregnancy. Int J Gynaecol Obstet 2001;72:189-90
31. Mattos MS. Calazar. In: Schechter M, Marangoni DV, eds. Doenças Infecciosas: Conduta Diagnóstica e Terapêutica, 2nd edn. Rio de Janeiro: Guanabara Koogan, 1998
32. De Raadt P. Congenital trypanosomiasis and leishmaniasis. Arch Fr Pediatr 1985;42(Suppl 2):925-7
33. Winship KA. Toxicity of antimony and its compounds. Adverse Drug Acute Poisoning Rev 1987;6:67-90
34. Paumgartten FJ, Chahoud I. Embryotoxicity of meglumine antimoniate in the rat. Reprod Toxicol 2001;15:327-31
35. Leonard A, Gerber GB. Mutagenicity, carcinogenicity and teratogenicity of antimony compounds. Mutat Res 1996;366:1-8
36. Marsden PD. Old drugs for new diseases. Rev Soc Bras Med Trop 1985;18:187-98
37. Mish M, Biswas UK, Jha DN, Khan AB. Amphotericin B for second-line treatment of Indian kala-azar. Lancet 1990;337:926
38. Giri OP. Amphotericin B therapy in kala-azar. J Assoc Phys India 1993;4:91-93
39. Thakur CP, Singh SM, Hassan RK et al. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg 1999;93:319-328
40. Wegmann TG, Lin H, Guilbert LJ, et al. Bidirectional cytokine interections in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353-6
41. Krishnan L, Guilbert LJ, Russel AS, et al. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gama responses and increased production of T helper 2 cytokines. J Immunol 1996;156:644-52